Medical Design Technology

Ear/Nose/Throat

Subscribe to Ear/Nose/Throat

Vitamin D Levels Lower in African-Americans

September 29, 2010 11:34 am | by AACR | News | Comments

• Lower levels may be linked to aggressive breast cancer. • Findings suggest possible prevention strategy. • Vitamin D levels should be monitored closely. MIAMI — African-American women had lower vitamin D levels than white women, and vitamin D deficiency was associated with a greater...

Method to Detect Bladder Cancer Earlier is Under Development

September 28, 2010 12:31 pm | by AACR | News | Comments

DENVER — Scientists may have discovered a way to diagnose bladder cancer at its earliest and, therefore, most treatable stages by measuring the presence or absence of microRNA using already available laboratory tests.

Sleep Solutions, Inc. Re-incorporates as NovaSom, Inc.

September 28, 2010 10:31 am | by Bio-Medicine.Org | News | Comments

GLEN BURNIE, Md., Sept. 28 /- Sleep Solutions, the pioneer and largest national service provider of home sleep tests for obstructive sleep apnea (OSA), has changed its name to NovaSom, Inc., a Delaware corporation. The company changed its name to better reflect its history and commitment...

Advertisement

Gloria Gaynor to Appear at AARP's Orlando@50+ National Event & Expo

September 28, 2010 7:32 am | by Bio-Medicine.Org | News | Comments

PARSIPPANY, N.J., Sept. 28 /- Grammy Award winner Gloria Gaynor -- whose hit songs have captivated the public for over 35 years -- will appear at AARP's Orlando@50+ National Event & Expo to raise awareness of knee osteoarthritis (OA), including her own experience with this potentially...

First Franchise Urgent Care Clinic to Open

September 27, 2010 12:31 am | by San Diego Business Journal | News | Comments

A longtime local health care executive is hoping to attract some of the county’s urgent care business when he opens the first franchise clinic of a national chain tailored to these types of patients.

Results From Argos Therapeutics' Arcelis™ Immunotherapy Phase 2 Study for Treatment of Renal Cell Carcinoma (RCC) Accepted for Poster Presentation at Ninth International Kidne...

September 24, 2010 6:33 am | by Bio-Medicine.Org | News | Comments

DURHAM, N.C., Sept. 24 /- Argos Therapeutics today announced that results from its Arcelis™ immunotherapy Phase 2 study for the treatment of renal cell carcinoma (RCC) have been accepted for a poster presentation at the Ninth International Kidney Cancer Symposium on Oct. 1-2 in...

Tolerx begins trials for juvenile diabetes treatment

September 23, 2010 11:32 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Tolerx Inc. has enrolled its first patient in a late-stage clinical trial for a potential therapy to treat type 1 — juvenile — diabetes. If the drug is later approved, it would be the first one-time therapy for the disease.

ENTrigue Surgical, Inc. Announces Initial Clinical Experience with Ventera™ Sinus Dilation Systems and the Commercial Launch of Synaero™ Hemostasis Product

September 23, 2010 5:25 am | News | Comments

SAN ANTONIO, Sept. 23 /PRNewswire/ -- ENTrigue Surgical, Inc. ("ENTrigue"), a San Antonio, Texas-based company that designs, develops, manufactures and distributes medical devices used for Ear, Nose and Throat surgical procedures, announced today the first clinical experience with its Ventera™ sinus dilation systems.

Advertisement

Reportlinker Adds IP Overview - "Monoclonal Antibodies against digestive system cancers" Patent Landscape 2010

September 21, 2010 12:31 pm | by Bio-Medicine.Org | News | Comments

NEW YORK, Sept. 21 /- Reportlinker.com announces that a new market research report is available in its catalogue: IP Overview – "Monoclonal Antibodies against digestive system cancers" Patent Landscape 2010...

National Health Education Campaign: "When Will You Pick?"™ Encourages Families to Make Flu Vaccination a Priority This Fall

September 21, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

GAITHERSBURG, Md., Sept. 21 /- New school schedules, exciting sporting events, and daily homework assignments are already keeping families busy this fall. But how many have taken time to get their annual flu vaccinations? The U.S. Centers for Disease Control and Prevention (CDC) advises...

Pittsburgh Life Sciences Greenhouse Executive-in-Residence Launches Medical Device Company

September 21, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

PITTSBURGH, Sept. 21 /- The Pittsburgh Life Sciences Greenhouse (PLSG), the organization providing capital investments and customized company formation and business growth programs to western Pennsylvania's life sciences enterprises, announced today that one of its nationally recognized...

Accuray Incorporated to Speak at JMP Securities Healthcare Conference

September 20, 2010 7:32 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., Sept. 20 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today that its management is scheduled to present at the JMP Securities Healthcare Conference in New York City on Tuesday, September 28, 2010 at 11:30 a.m. ET/8:30...

Lantos Technologies Closes on $1.6 Million Series A Financing to Support Development of World’s First Real-time 3D Ear Canal Scanning Technology

September 17, 2010 7:55 am | News | Comments

Cambridge, MA, September 16, 2010 — Lantos Technologies, Inc. today announced it has closed on $1.6 million in a Series A financing.  Catalyst Health Ventures led the round, which was joined by additional investors Excel Venture Management and Mass Medical Angels.

Fact or Fiction: ADHD in America, a Capitol Hill Forum

September 16, 2010 9:35 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, Sept. 16 /- Shire plc (LSE: SHP, Nasdaq: SHPGY ), the global specialty biopharmaceutical company, has partnered with the Entertainment Industries Council (EIC) , the Lab School of Washington and other organizations in support of National Attention Deficit Hyperactivity...

Access Pharmaceuticals Launches MuGard Product Website

September 15, 2010 6:31 am | by Bio-Medicine.Org | News | Comments

DALLAS and NEW YORK, Sept. 15 /- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP ), a biopharmaceutical company specializing in products for cancer and supportive care, announced today it has launched www.MuGard.com .  The patient- and healthcare professional- focused site is...

Humidifiers Just Got More Fun for Kids - Vicks Launches Starry Night Cool Moisture Humidifier

September 14, 2010 7:36 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Sept. 14 /- Getting kids excited about humidifiers is tough to say the least, particularly when they're dragged out of the closet only when little ones are sick.  The American Academy of Pediatrics, however, recommends using a cool mist humidifier throughout the winter...

North American Spine Welcomes Kenneth Alo, M.D. to Physician Group

September 13, 2010 8:32 am | by Bio-Medicine.Org | News | Comments

HOUSTON, Sept. 13 /- North American Spine is pleased to announce that Kenneth Alo, M.D. has joined to help further the advancement of minimally invasive pain treatment techniques used to both diagnose and treat inter-vertebral lumbar discs, spinal stenosis and many other causes of back...

Study to control blood pressure in diabetics enrolling

September 10, 2010 11:32 am | by Baylor College of Medicine | News | Comments

Most people believe controlling blood sugar levels is the only concern for people with diabetes. However, doctors at Baylor College of Medicine say there are more health concerns that must be managed to save the life of a diabetic. "One of the leading causes of death for people with...

Updated Phase 2 Data With Flutemetamol Published in Annals of Neurology

September 8, 2010 6:31 am | by Bio-Medicine.Org | News | Comments

PRINCETON, N.J., Sept. 7 /- GE Healthcare announced today that results from its multicenter phase 2 study of flutemetamol were published in the September issue of Annals of Neurology . Flutemetamol is an investigational positron emission tomography (PET) imaging agent being developed by...

CyberKnife Treatment for Prostate Cancer

September 3, 2010 6:32 am | by Bio-Medicine.Org | News | Comments

MIAMI, Sept. 3 /- CyberKnife radiosurgery treatment for prostate cancer is rapid, effective and has no side effects, with the added benefit of being non-invasive. Since 2003, the CyberKnife Center of Miami and the CyberKnife Center of Palm Beach have been providing this high tech cancer...

Baylor/UT Health Center for AIDS Research receives five year renewal

August 27, 2010 1:36 pm | by Baylor College of Medicine | News | Comments

The Baylor College of Medicine and The University of Texas Health Science Center at Houston's Center for AIDS Research has received a five-year renewal from the National Institutes of Health . The center was established at BCM in 1994 and partnered with UTHealth in 2004. It is designed to...

Award-Winning U.S. Talk Show Host Montel Williams Joins Rex Bionics New International Advisory Board

August 24, 2010 6:34 am | by Bio-Medicine.Org | News | Comments

NORTH HARBOUR, New Zealand, Aug. 24 /- Rex Bionics Ltd., the company developing a robotic exoskeleton enabling wheelchair users to walk, announced formation of an International Advisory Board that includes Emmy Award-winning U.S. talk show host Montel Williams .  Also named to the...

Preliminary Research Results Suggest up to 70% Reduction in Dose for Positron Emission Mammography Imaging

August 23, 2010 10:31 pm | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Aug. 24 /- In a recent study presented at the American Association of Physicists in Medicine (AAPM) 52nd Annual Meeting, researchers at the University of Washington showed that 18FDG dose for Positron Emission Mammography (PEM) may be reduced by as much as 70% without altering...

Stars Align for Historic Stand Up To Cancer Event

August 19, 2010 6:32 am | by AACR | News | Comments

LA & NYC (www.standup2cancer.org) – An extraordinary line-up of actors, musicians, athletes and journalists have banded together for Stand Up To Cancer (SU2C), the groundbreaking initiative aimed at raising funds to accelerate innovative cancer research bringing new therapies to...

Life sciences firms explore ways to help developing nations

August 18, 2010 8:33 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Is it possible to solve a developing-world pandemic or other similar disease that afflicts the poor and still get rich? One might have to choose between one or the other, say experts, but there may be some options.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading